1-20 of 158
Jens J Holst
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis

Magnus F.G. Grøndahl, Andreas H. Lange, Malte P. Suppli, Jonatan I. Bagger, Mira Thing, Lise L. Gluud, Dea H. Kofod, Mads Hornum, Gerrit van Hall, Samuel A.J. Trammell, Trisha J. Grevengoed, Bolette Hartmann, Jens J. Holst, Tina Vilsbøll, Mikkel B. Christensen, Asger B. Lund, Filip K. Knop
Journal: Diabetes
Diabetes 2024;73(10):1641–1647
https://doi.org/10.2337/db24-0305
Published: 25 July 2024
View articletitled, Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis
Open the PDF for Glucagon Clearance Is Decreased in Chronic Kidney Disease but Preserved in Liver Cirrhosis in another window
Journal Articles

Glucagon Resistance in Individuals With Obesity and Hepatic Steatosis Can Be Measured Using the GLUSENTIC Test and Index

Sasha A.S. Kjeldsen, Michael M. Richter, Nicole J. Jensen, Malin S.D. Nilsson, Niklas Heinz, Janus D. Nybing, Frederik H. Linden, Erik Høgh-Schmidt, Mikael P. Boesen, Thomas L. Andersen, Helle H. Johannesen, Samuel A.J. Trammell, Trisha J. Grevengoed, Sten Madsbad, Hendrik Vilstrup, Frank Vinholt Schiødt, Andreas Møller, Elias B. Rashu, Kirsten Nørgaard, Signe Schmidt, Lise L. Gluud, Steen B. Haugaard, Jens J. Holst, Jørgen Rungby, Nicolai J. Wewer Albrechtsen
Journal: Diabetes
Diabetes 2024;73(10):1716–1727
https://doi.org/10.2337/db23-0858
Published: 08 July 2024
View articletitled, Glucagon Resistance in Individuals With Obesity and Hepatic Steatosis Can Be Measured Using the GLUSENTIC Test and Index
Open the PDF for Glucagon Resistance in Individuals With Obesity and Hepatic Steatosis Can Be Measured Using the GLUSENTIC Test and Index in another window
Meeting Abstracts

108-OR: Insulin Resistance Is Associated with Alterations in the Dynamics of Incretin Secretion

GIANFRANCO DI GIUSEPPE, LAURA SOLDOVIERI, GEA CICCARELLI, MICHELA BRUNETTI, FRANCESCA CINTI, SIMONA MOFFA, JENS J. HOLST, ANDREA GIACCARI, TERESA MEZZA
Journal: Diabetes
Diabetes 2024;73(Supplement_1):108-OR
https://doi.org/10.2337/db24-108-OR
Published: 14 June 2024
View articletitled, 108-OR: Insulin Resistance Is Associated with Alterations in the Dynamics of Incretin Secretion
Meeting Abstracts

1620-P: Vagus Nerve Integrity Is Critical for GLP-1 (7-36) Safeness against Hypoglycemia

CAROLINA B. LOBATO, JENS J. HOLST
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1620-P
https://doi.org/10.2337/db24-1620-P
Published: 14 June 2024
View articletitled, 1620-P: Vagus Nerve Integrity Is Critical for GLP-1 (7-36) Safeness against Hypoglycemia
Meeting Abstracts

1619-P: Insulin Resistance Stimulates Intraislet GLP-1 Secretion from a-Cells in Diet-Induced Obese Mice

GIANFRANCO DI GIUSEPPE, SARA L. JEPSEN, JON VERGARA UCIN, BOLETTE HARTMANN, ANDREA GIACCARI, JENS J. HOLST, TERESA MEZZA
Journal: Diabetes
Diabetes 2024;73(Supplement_1):1619-P
https://doi.org/10.2337/db24-1619-P
Published: 14 June 2024
View articletitled, 1619-P: Insulin Resistance Stimulates Intraislet GLP-1 Secretion from a-Cells in Diet-Induced Obese Mice
Journal Articles

In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice

Mark M. Smits, Katrine D. Galsgaard, Sara Lind Jepsen, Nicolai Wewer Albrechtsen, Bolette Hartmann, Jens J. Holst
Journal: Diabetes
Diabetes 2024;73(5):671–681
https://doi.org/10.2337/db23-0848
Published: 31 January 2024
View articletitled, In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice
Open the PDF for In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice in another window
Meeting Abstracts

1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans

MAGNUS F.G. GRØNDAHL, CAROLINE T. JUEL, ASGER LUND, SOFIE HAEDERSDAL, MARIA M. ANDERSEN, JENS S. SVENNINGSEN, MATTHEW GILLUM, BOLETTE HARTMANN, JENS J. HOLST, TINA VILSBØLL, FILIP K. KNOP
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1651-P
https://doi.org/10.2337/db23-1651-P
Published: 20 June 2023
View articletitled, 1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
Meeting Abstracts

1754-P: Reduced Incretin Effect Predicts Diabetes Appearance in a Cohort of Nondiabetic Subjects after Acute Beta-Cell Mass Reduction

GIANFRANCO DI GIUSEPPE, CHIARA MARIA ASSUNTA CEFALO, SIMONA MOFFA, GEA CICCARELLI, LAURA SOLDOVIERI, FRANCESCA CINTI, UMBERTO CAPECE, FLAVIA IMPRONTA, ANDREA MARI, JENS J. HOLST, ANDREA GIACCARI, TERESA MEZZA
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1754-P
https://doi.org/10.2337/db23-1754-P
Published: 20 June 2023
View articletitled, 1754-P: Reduced Incretin Effect Predicts Diabetes Appearance in a Cohort of Nondiabetic Subjects after Acute Beta-Cell Mass Reduction
Meeting Abstracts

244-OR: Signs of Glucagon Resistance after a Two-Week Hypercaloric Diet Intervention

MALTE P. SUPPLI, JONATAN I. BAGGER, SR., JENS J. HOLST, FILIP K. KNOP
Journal: Diabetes
Diabetes 2023;72(Supplement_1):244-OR
https://doi.org/10.2337/db23-244-OR
Published: 20 June 2023
View articletitled, 244-OR: Signs of Glucagon Resistance after a Two-Week Hypercaloric Diet Intervention
Meeting Abstracts

1378-P: Habitual High Sodium Intake Is Associated with Alterations in Glucose Homeostasis Including GLP-1 Secretion

ANNA DONKERS, HANNA HUBER, ALINA SCHIEREN, AAKASH MANTRI, WALDEMAR SEEL, BIRGIT STOFFEL-WAGNER, MARTIN COENEN, PETER KRAWITZ, JENS J. HOLST, PETER STEHLE, MARIE-CHRISTINE SIMON
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1378-P
https://doi.org/10.2337/db23-1378-P
Published: 20 June 2023
View articletitled, 1378-P: Habitual High Sodium Intake Is Associated with Alterations in Glucose Homeostasis Including GLP-1 Secretion
Journal Articles

The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery

Morten Hindsø, Nora Hedbäck, Maria S. Svane, Andreas Møller, Christoffer Martinussen, Nils B. Jørgensen, Carsten Dirksen, Lærke S. Gasbjerg, Viggo B. Kristiansen, Bolette Hartmann, Mette M. Rosenkilde, Jens J. Holst, Sten Madsbad, Kirstine N. Bojsen-Møller
Journal: Diabetes
Diabetes 2023;72(3):336–347
https://doi.org/10.2337/db22-0568
Published: 07 December 2022
View articletitled, The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery
Open the PDF for The Importance of Endogenously Secreted GLP-1 and GIP for Postprandial Glucose Tolerance and β-Cell Function After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy Surgery in another window
Journal Articles

Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes

Signe Stensen, Lærke S. Gasbjerg, Mette M. Rosenkilde, Tina Vilsbøll, Jens J. Holst, Bolette Hartmann, Mikkel B. Christensen, Filip K. Knop
Journal: Diabetes
Diabetes 2022;71(10):2209–2221
https://doi.org/10.2337/db22-0059
Published: 07 July 2022
View articletitled, Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes
Open the PDF for Endogenous Glucose-Dependent Insulinotropic Polypeptide Contributes to Sitagliptin-Mediated Improvement in β-Cell Function in Patients With Type 2 Diabetes in another window
Journal Articles

The Liver–α-Cell Axis in Health and in Disease

Michael M. Richter, Katrine D. Galsgaard, Emilie Elmelund, Filip K. Knop, Malte P. Suppli, Jens J. Holst, Marie Winther-Sørensen, Sasha A.S. Kjeldsen, Nicolai J. Wewer Albrechtsen
Journal: Diabetes
Diabetes 2022;71(9):1852–1861
https://doi.org/10.2337/dbi22-0004
Published: 03 June 2022
View articletitled, The Liver–α-Cell Axis in Health and in Disease
Open the PDF for The Liver–α-Cell Axis in Health and in Disease in another window
Meeting Abstracts

321-OR: Empagliflozin Improves Beta-Cell Function Independently of Glucose Toxicity in Patients with Type 2 Diabetes

ROOPAMEERA THIRUMATHYAM, ERIK A. RICHTER, JENS PETER GOETZE, PER L. MADSEN, JENS J. HOLST, STEN MADSBAD, SR., NILS B. JØRGENSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):321-OR
https://doi.org/10.2337/db22-321-OR
Published: 01 June 2022
View articletitled, 321-OR: Empagliflozin Improves Beta-Cell Function Independently of Glucose Toxicity in Patients with Type 2 Diabetes
Meeting Abstracts

214-LB: Activating and Disrupting the Liver–Alpha-Cell Axis Respectively Enhances and Impairs Amino Acid Metabolism and Alpha-Cell Growth

EMILIE E. CHRISTENSEN, KATRINE D. GALSGAARD, CHRISTIAN D. JOHANSEN, SAMUEL TRAMMELL, ANNA B. BOMHOLT, JENNA HUNT, THOMAS KRUSE, JESPER F. LAU, TRISHA GREVENGOED, JENS J. HOLST, NICOLAI J. WEWER ALBRECHTSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):214-LB
https://doi.org/10.2337/db22-214-LB
Published: 01 June 2022
View articletitled, 214-LB: Activating and Disrupting the Liver–Alpha-Cell Axis Respectively Enhances and Impairs Amino Acid Metabolism and Alpha-Cell Growth
Meeting Abstracts

271-OR: Hepatic Glucagon Resistance in Mice with Nonalcoholic Fatty Liver Disease

FREDERIK R. CEUTZ, EMILIE E. CHRISTENSEN, MARIE WINTHER-SOERENSEN, HENDRIK VILSTRUP, JENS J. HOLST, NICOLAI J. WEWER ALBRECHTSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):271-OR
https://doi.org/10.2337/db22-271-OR
Published: 01 June 2022
View articletitled, 271-OR: Hepatic Glucagon Resistance in Mice with Nonalcoholic Fatty Liver Disease
Meeting Abstracts

235-OR: Sustained QTc Prolongation during Recovery from Hypoglycemia in Patients with Type 1 Diabetes

CHRISTINE R. ANDREASEN, ANDREAS ANDERSEN, PER G. HAGELQVIST, JULIUS V. LAURITSEN, SUSANNE ENGBERG, JENS J. HOLST, ULRIK PEDERSEN-BJERGAARD, FILIP K. KNOP, TINA VILSBØLL
Journal: Diabetes
Diabetes 2022;71(Supplement_1):235-OR
https://doi.org/10.2337/db22-235-OR
Published: 01 June 2022
View articletitled, 235-OR: Sustained QTc Prolongation during Recovery from Hypoglycemia in Patients with Type 1 Diabetes
Meeting Abstracts

876-P: Empagliflozin-Induced Metabolic Changes and Cardiac Function in Patients with Type 2 Diabetes: A Randomized Crossover MRI Study with Insulin as Comparator

ROOPAMEERA THIRUMATHYAM, JENS PETER GOETZE, JENS J. HOLST, NIELS VEJLSTRUP, STEN MADSBAD, SR., PER L. MADSEN, NILS B. JØRGENSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):876-P
https://doi.org/10.2337/db22-876-P
Published: 01 June 2022
View articletitled, 876-P: Empagliflozin-Induced Metabolic Changes and Cardiac Function in Patients with Type 2 Diabetes: A Randomized Crossover MRI Study with Insulin as Comparator
Meeting Abstracts

1362-P: Endogenous Glucose-Dependent Insulinotropic Polypeptide Facilitates Postprandial Intestinal Lipid Uptake in Healthy Men, but Not in Patients with Type 2 Diabetes

LÆRKE S. GASBJERG, MADS M. HELSTED, SIGNE STENSEN, LIVA S.L. KROGH, ALEXANDER H. SPARRE-ULRICH, BOLETTE HARTMANN, TINA VILSBØLL, MIKKEL B. CHRISTENSEN, JENS J. HOLST, CHRISTINA CHRISTOFFERSEN, FILIP K. KNOP, METTE M. ROSENKILDE
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1362-P
https://doi.org/10.2337/db22-1362-P
Published: 01 June 2022
View articletitled, 1362-P: Endogenous Glucose-Dependent Insulinotropic Polypeptide Facilitates Postprandial Intestinal Lipid Uptake in Healthy Men, but Not in Patients with Type 2 Diabetes
Meeting Abstracts

1343-P: The Acute Effects of Glucagon on Glucose Dynamics Are Not Impaired in Individuals with Nonalcoholic Fatty Liver Disease

SASHA KJELDSEN, NICOLE J. JENSEN, MALIN NILSSON, NIKLAS HEINZ, JANUS D. NYBING, FREDERIK H. LINDEN, ERIK HØGH-SCHMIDT, MIKAEL P. BOESEN, STEN MADSBAD, HENDRIK VILSTRUP, SR., FRANK V. SCHIØDT, ANDREAS MØLLER, ELIAS B. RASHU, LISE GLUUD, STEEN B. HAUGAARD, JENS J. HOLST, JOERGEN RUNGBY, NICOLAI J. WEWER ALBRECHTSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):1343-P
https://doi.org/10.2337/db22-1343-P
Published: 01 June 2022
View articletitled, 1343-P: The Acute Effects of Glucagon on Glucose Dynamics Are Not Impaired in Individuals with Nonalcoholic Fatty Liver Disease